Ultragenyx Pharmaceutical (RARE) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 7.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.57% |
| Dec 31, 2025 | 16.01% |
| Sep 30, 2025 | 19.73% |
| Jun 30, 2025 | 19.70% |
| Mar 31, 2025 | 10.50% |
| Dec 31, 2024 | 8.31% |
| Sep 30, 2024 | -9.04% |
| Jun 30, 2024 | 5.65% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -57.30% |
| Sep 30, 2023 | -25.43% |
| Jun 30, 2023 | -94.49% |
| Mar 31, 2023 | -4.36% |
| Dec 31, 2022 | -10.06% |
| Sep 30, 2022 | -21.32% |
| Jun 30, 2022 | -9.53% |
| Mar 31, 2022 | -6.36% |
| Dec 31, 2021 | -1.14% |
| Sep 30, 2021 | 14.70% |
| Jun 30, 2021 | -19.52% |
| Mar 31, 2021 | -73.49% |
| Dec 31, 2020 | 41.94% |
| Sep 30, 2020 | 15.46% |
| Jun 30, 2020 | 30.92% |
| Mar 31, 2020 | -7.94% |
| Dec 31, 2019 | 2.54% |
| Sep 30, 2019 | -6.12% |
| Jun 30, 2019 | -5.61% |
| Mar 31, 2019 | -10.47% |
| Dec 31, 2018 | -6.80% |
| Sep 30, 2018 | -19.10% |
| Jun 30, 2018 | -8.49% |
| Mar 31, 2018 | 44.22% |
| Dec 31, 2017 | -53.75% |
| Sep 30, 2017 | -55.22% |
| Jun 30, 2017 | -56.35% |
| Mar 31, 2017 | -24.24% |
| Dec 31, 2016 | 29.43% |
| Sep 30, 2016 | 22.18% |
| Jun 30, 2016 | 23.95% |
| Mar 31, 2016 | 21.96% |